Formoterol Fumarate | Annual Sales Report | Pharmacompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Formoterol Fumarate
Annual Reports

PharmaCompass Sponsored Ads

Contact Supplier

Vamsi labs Formoterol Fumarate

Contact Supplier

IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

Coral

Contact Supplier

ICE Pharma offers a unique range of bile acid products and best-in-class services for the pharmaceutical industry.

Contact Supplier

Formoterol Fumarate

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

51 API Suppliers, 16 USDMF, 14 CEP/COS, 4 JDMF, 8 EU WC, 12 KDMF, 21 NDC API, 28 Listed Suppliers, $ API Reference Price

51 API Suppliers
16 USDMF
14 CEP/COS
4 JDMF
8 EU WC
12 KDMF
21 NDC API
28 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

248 Drugs in Development

248 Drugs in Development

INTERMEDIATES

12 Intermediate Suppliers

12 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

844 FDF Dossiers, 24 FDA Orange Book, 747 Europe, 8 Canada, 6 Australia, 12 South Africa, 47 Listed Dossiers

844 FDF Dossiers
24 FDA Orange Book
747 Europe
8 Canada
6 Australia
12 South Africa
47 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

POWDER;INHALATION - 0.012MG/INH **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, POWDER, METERED;INHALATION - 0.4MG/INH;0.012MG/INH, AEROSOL, METERED;INHALATION - 0.08MG/INH;0.0045MG/INH, AEROSOL, METERED;INHALATION - 0.16MG/INH;0.0045MG/INH, AEROSOL, METERED;INHALATION - 0.005MG/INH;0.05MG/INH, AEROSOL, METERED;INHALATION - 0.005MG/INH;0.1MG/INH, AEROSOL, METERED;INHALATION - 0.005MG/INH;0.2MG/INH

POWDER;INHALATION - 0.012MG/INH **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
POWDER, METERED;INHALATION - 0.4MG/INH;0.012MG/INH
AEROSOL, METERED;INHALATION - 0.08MG/INH;0.0045MG/INH
AEROSOL, METERED;INHALATION - 0.16MG/INH;0.0045MG/INH
AEROSOL, METERED;INHALATION - 0.005MG/INH;0.05MG/INH
AEROSOL, METERED;INHALATION - 0.005MG/INH;0.1MG/INH
AEROSOL, METERED;INHALATION - 0.005MG/INH;0.2MG/INH

RELATED EXCIPIENT COMPANIES

2 Nanjing Well Pharmaceutical, 4 Kirsch Pharma, 5 Actylis, 2 BASF, 1 CD Formulation, 1 Clariant, 1 Finar, 3 Kerry, 1 Microlex e.U, 1 Nippon Fine Chemical, 1 Roquette

2 Nanjing Well Pharmaceutical
4 Kirsch Pharma
5 Actylis
2 BASF
1 CD Formulation
1 Clariant
1 Finar
3 Kerry
1 Microlex e.U
1 Nippon Fine Chemical
1 Roquette

EXCIPIENTS BY APPLICATIONS

8 Parenteral, 3 Topical, 3 Controlled & Modified Release, 3 Thickeners and Stabilizers, 2 Granulation, 2 Direct Compression, 2 Emulsifying Agents, 2 Chewable & Orodispersible Aids, 2 Fillers, Diluents & Binders, 1 Coating Systems & Additives, 1 Dry Powder Inhalation, 1 Taste Masking, 1 Solubilizers, 1 Film Formers & Plasticizers, 1 Surfactant & Foaming Agents, 1 Lubricants & Glidants, 1 Co-Processed Excipients

8 Parenteral
3 Topical
3 Controlled & Modified Release
3 Thickeners and Stabilizers
2 Granulation
2 Direct Compression
2 Emulsifying Agents
2 Chewable & Orodispersible Aids
2 Fillers, Diluents & Binders
1 Coating Systems & Additives
1 Dry Powder Inhalation
1 Taste Masking
1 Solubilizers
1 Film Formers & Plasticizers
1 Surfactant & Foaming Agents
1 Lubricants & Glidants
1 Co-Processed Excipients

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 1 Stock Recap #PipelineProspector, 68 News #PharmaBuzz

1 Data Compilation #PharmaFlow
1 Stock Recap #PipelineProspector
68 News #PharmaBuzz

GLOBAL SALES INFORMATION

14 US Medicaid Prescriptions, 173 Regulatory FDF Prices, 81 Annual Reports

14 US Medicaid Prescriptions
173 Regulatory FDF Prices
81 Annual Reports

MARKET PLACE

12 APIs

12 APIs

PATENTS & EXCLUSIVITIES

18 US Patents, 24 Health Canada Patents

18 US Patents
24 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 2 USP, 10 Others

3 EDQM
2 USP
10 Others

$ API Ref.Price (USD/KG) : 77,446 Xls

Filters

Reset all filters

Filters

FILTER :

filter Product Reset all filters

81 All

01 7Bevespi

02 10Breztri

03 3Brovana

04 4Cortiment

05 5Duaklir

06 9Dulera

07 1Eohilia

08 1Foradil

09 11Pulmicort

10 23Symbicort

11 5Uceris

12 1Uceris/Cortiment

13 1Ultibro Group

Formoterol Fumarate

List of Suppliers

Product Main Page

01

Brand Name : Symbicort

Budesonide, Formoterol

Organic Process R&D

Not Confirmed

Brand Name : Symbicort

Organic Process R&D

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Budesonide, Formoterol

Main Therapeutic Indication : Respiratory Disorders

Currency : USD

2020 Revenue in Millions : 0

2019 Revenue in Millions : 213

Growth (%) : -100

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Brand Name : Symbicort

Budesonide, Glycopyrronium, Formoterol Fumarate

Organic Process R&D

Not Confirmed

Brand Name : Symbicort

Organic Process R&D

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

AstraZeneca

Budesonide, Glycopyrronium, Formoterol Fumarate

Main Therapeutic Indication : Respiratory Disorders

Currency : USD

2020 Revenue in Millions : 2,721

2019 Revenue in Millions : 2,495

Growth (%) : 9

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Brand Name : Cortiment

Budesonide, Glycopyrronium, Formoterol Fumarate

Organic Process R&D

Not Confirmed

Brand Name : Cortiment

Organic Process R&D

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Cosmo Pharmaceuticals

Budesonide, Glycopyrronium, Formoterol Fumarate

Main Therapeutic Indication : Respiratory Disorders

Currency : USD

2020 Revenue in Millions : 8

2019 Revenue in Millions : 5

Growth (%) : 70

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Brand Name : Uceris

Budesonide, Glycopyrronium, Formoterol Fumarate

Organic Process R&D

Not Confirmed

Brand Name : Uceris

Organic Process R&D

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Cosmo Pharmaceuticals

Budesonide, Glycopyrronium, Formoterol Fumarate

Main Therapeutic Indication : Respiratory Disorders

Currency : USD

2020 Revenue in Millions : 6

2019 Revenue in Millions : 11

Growth (%) : -48

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Brand Name : Pulmicort

Budesonide, Glycopyrronium, Formoterol Fumarate

Organic Process R&D

Not Confirmed

Brand Name : Pulmicort

Organic Process R&D

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

AstraZeneca

Budesonide, Glycopyrronium, Formoterol Fumarate

Main Therapeutic Indication : Respiratory Disorders

Currency : USD

2020 Revenue in Millions : 996

2019 Revenue in Millions : 1,466

Growth (%) : -32

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

Brand Name : Symbicort

Budesonide, Glycopyrronium, Formoterol Fumarate

Organic Process R&D

Not Confirmed

Brand Name : Symbicort

Organic Process R&D

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Budesonide, Glycopyrronium, Formoterol Fumarate

Main Therapeutic Indication : Respiratory Disorders

Currency : USD

2020 Revenue in Millions : 0

2019 Revenue in Millions : 213

Growth (%) : -100

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

Brand Name : Breztri

Budesonide, Glycopyrronium, Formoterol Fumarate

Organic Process R&D

Not Confirmed

Brand Name : Breztri

Organic Process R&D

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

AstraZeneca

Budesonide, Glycopyrronium, Formoterol Fumarate

Main Therapeutic Indication : Respiratory Disorders

Currency : USD

2020 Revenue in Millions : 28

2019 Revenue in Millions : 2

Growth (%) : 1,300

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

Brand Name : Symbicort

Budesonide, Formoterol

Organic Process R&D

Not Confirmed

Brand Name : Symbicort

Organic Process R&D

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

AstraZeneca

Budesonide, Formoterol

Main Therapeutic Indication : Respiratory Disorders

Currency : USD

2020 Revenue in Millions : 2,721

2019 Revenue in Millions : 2,495

Growth (%) : 9

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

Brand Name : Bevespi

Formoterol Fumarate

Organic Process R&D

Not Confirmed

Brand Name : Bevespi

Organic Process R&D

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

AstraZeneca

Formoterol Fumarate

Main Therapeutic Indication : Respiratory Disorders

Currency : USD

2020 Revenue in Millions : 48

2019 Revenue in Millions : 42

Growth (%) : 14

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

Brand Name : Breztri

Formoterol Fumarate

Organic Process R&D

Not Confirmed

Brand Name : Breztri

Organic Process R&D

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

AstraZeneca

Formoterol Fumarate

Main Therapeutic Indication : Respiratory Disorders

Currency : USD

2021 Revenue in Millions : 203

2020 Revenue in Millions : 28

Growth (%) : 625

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2
3
Last

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!